Enovis Corporation (ENOV)
- Previous Close
51.71 - Open
52.15 - Bid --
- Ask --
- Day's Range
51.79 - 53.38 - 52 Week Range
43.04 - 66.14 - Volume
730,258 - Avg. Volume
513,924 - Market Cap (intraday)
2.88B - Beta (5Y Monthly) 2.07
- PE Ratio (TTM)
-- - EPS (TTM)
-1.90 - Earnings Date Aug 1, 2024 - Aug 5, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
74.10
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
www.enovis.com6,550
Full Time Employees
December 31
Fiscal Year Ends
Sector
Specialty Industrial Machinery
Industry
Recent News: ENOV
Performance Overview: ENOV
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ENOV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ENOV
Valuation Measures
Market Cap
2.88B
Enterprise Value
4.23B
Trailing P/E
--
Forward P/E
19.80
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.58
Price/Book (mrq)
0.87
Enterprise Value/Revenue
2.33
Enterprise Value/EBITDA
27.06
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.51%
Return on Assets (ttm)
-0.03%
Return on Equity (ttm)
-3.04%
Revenue (ttm)
1.82B
Net Income Avi to Common (ttm)
-103.33M
Diluted EPS (ttm)
-1.90
Balance Sheet and Cash Flow
Total Cash (mrq)
66.27M
Total Debt/Equity (mrq)
42.68%
Levered Free Cash Flow (ttm)
20.46M
Research Analysis: ENOV
Company Insights: ENOV
ENOV does not have Company Insights